PT  - JOURNAL ARTICLE
AU  - Saadeh, Sherif
AU  - Younossi, Zobair M.
TI  - The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
DP  - 2000 Feb 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 96--104
VI  - 67
IP  - 2
4099  - http://www.ccjm.org/content/67/2/96.short
4100  - http://www.ccjm.org/content/67/2/96.full
SO  - Cleve Clin J Med2000 Feb 01; 67
AB  - Nonalcoholic fatty liver disease (NAFL) has been recognized only in the past 20 years. Autopsy studies indicate it is remarkably common, especially among obese persons and patients with type 2 diabetes. Although fatty liver alone is usually benign, an identifiable subset of patients may be at risk of progression to cirrhosis and liver failure. The role of liver biopsy is controversial. No specific, effective therapy as yet exists, although management of weight, lipid levels, and glucose levels is recommended.